Tag: FIBRONEER

Boehringer Ingelheim to submit nerandomilast for IPF treatment approval

Ingelheim, Germany- September 2024- Boehringer Ingelheim announced that the FIBRONEERโ„ข-IPF trial met…

ME Desk